Using a Web Platform for Equitable Distribution of COVID-19 Monoclonal Antibodies A Case Study in Resource Allocation

The authors of this article sought to incorporate ethical considerations into equitable distribution of monoclonal antibodies (mAbs) for COVID-19. The centralized access platform assessed patient criteria compared with the mAbs emergency use authorization and created a scoring system to prioritize eligible patients in times of scarcity.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.